Table 2.
Demographics, clinical parameters and outcomes of ICU-admitted patients eligible for VV-ECMO under any criteria (EOLIA, ELSO, NSW, CCSO, Regina-restrictive) compared to patients who met neither criteria.
| Eligible for VV-ECMO (n = 42) | Non-eligible for VV-ECMO (n = 373) | p-value | All patients (n = 415) | Missing observations (N) | |
|---|---|---|---|---|---|
| Age, median years (IQR) | 65 (49–72) | 60 (46–71) | 0.25 | 61 (46–71) | 0 |
| Male gender, N (%) | 33 (78.6%) | 217 (58.2%) | 0.01 | 250 (60.2%) | 0 |
| Charlson Comorbidity Index, median score (IQR) | 1 (0–3) | 2 (1–3) | 0.33 | 1 (1–3) | 0 |
| Sequential Organ Failure Assessment, median score (IQR) | 8 (6–10) | 7 (5–9) | 0.04 | 7 (5–9) | 0 |
| Clinical Frailty Score (IQR) | 3 (2–4) | 3 (3–4) | 0.02 | 3 (3–4) | 0 |
| Body Mass Index, median kg/m2 (IQR) | 29 (26–36) | 28 (23–34) | 0.09 | 28 (23–34) | 0 |
| Need for dialysis, N (%) | 5 (11.9%) | 17 (4.6%) | 0.06 | 22 (5.4%) | 5 |
| COVID-19, N (%) | 7 (16.7%) | 41 (11.0%) | 0.30 | 48 (11.6%) | 0 |
| Set VT, median mL/kg (IQR) | 7.6 (7.1–8.1) | 7.8 (7.2–8.3) | 0.35 | 7.8 (7.2–8.3) | 12 |
| Actual delivered VT, median mL/kg (IQR) | 8.4 (7.8–10.1) | 8.5 (7.8–9.8) | 0.91 | 8.5 (7.8–9.7) | 4 |
| Prone positioning, N (%) | 20 (47.6%) | 38 (10.2%) | < 0.001 | 58 (14.0%) | 0 |
| Neuromuscular blockade, N (%) | 21 (50.0%) | 51 (13.7%) | < 0.001 | 72 (17.3%) | 0 |
| Nitric oxide, N (%) | 5 (11.9%) | 6 (1.6%) | < 0.001 | 11 (2.7%) | 0 |
| Hospital length of stay, median days (IQR) | 17 (8–25) | 14 (8–32) | 0.73 | 14 (8–31) | 0 |
| ICU length of stay, median days (IQR) | 11 (3–19) | 6 (4–12) | 0.07 | 7 (4–12) | 0 |
| In-hospital mortality, N (%) | 23 (54.8%) | 113 (30.3%) | 0.001 | 136 (32.8%) | 0 |
CCSO Critical Care Services Ontario, COVID-19 Coronavirus-19, ELSO Extracorporeal Life Support Organization, EOLIA Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome, ICU intensive care unit, IQR interquartile range, NSW New South Wales, VT tidal volume, VV-ECMO veno-venous extracorporeal membrane oxygenation.